semaglutide and cardiovascular outcomes in obesity without diabetes journal club Evaluating the Cardiovascular Benefits of

Reach out today and lets talk about what works for your body, not just the numbers on a scale

As a small molecule weighing approximately 529 Da, orforglipron binds to an allosteric pocket within the transmembrane domain of the GLP-1 receptor, stabilizing the active receptor conformation and driving downstream signaling through Gs protein coupling and cAMP accumulation

Kopple JD

Overall, Tirzepatide tends to produce greater average weight loss than Semaglutide , likely because it targets two metabolic pathways instead of one

How does bariatric surgery compare to long-term use of GLP-1 medication

Antisense oligonucleotides targeted against glucocorticoid receptor reduce hepatic glucose production and ameliorate hyperglycemia in diabetic mice